Skip to Content
 

News: Skin Cancer

Potential second-line melanoma treatment identified

Friday, August 30th, 2019

A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients.

Vanderbilt Dermatology to offer free skin cancer screening June 15

Friday, May 3rd, 2019

Vanderbilt Dermatology in collaboration with the Nashville Dermatology Society is offering free skin cancer screenings on Saturday, June 15, from 9 a.m. to noon at Vanderbilt Health One Hundred Oaks, 719 Thompson Lane, Suite 26300.

Feeling Good in Your Own Skin: Melanoma Educational Program

Wednesday, May 16th, 2018

Feeling Good in Your Own Skin is a free educational event for patients, caregivers and survivors to learn about advancements in melanoma research, clinical care, and survivorship.

DNA damage repair: molecular insights

Thursday, December 7th, 2017

The first line of defense against skin cancer is the ability to repair DNA damage caused by UV light. Walter J. Chazin, PhD, and colleagues investigated how XPA – a protein involved in the repair of certain DNA damage – interacts with DNA and the effects of several disease-associated mutations in XPA on its molecular structure and ability to bind DNA.

Transplant Center initiative seeks to boost cancer education

Thursday, February 11th, 2016

Lindsay Ramsey Smith, MSN, R.N., a quality consultant for the Vanderbilt Transplant Center (VTC), recently uncovered some interesting data that sparked a center-wide improvement project. Every year the center reports all malignancies to the United Network for Organ Sharing (UNOS). During one of the reporting cycles, Smith noticed that a large portion of Vanderbilt patients […]

Veterans returning from Middle East face higher skin cancer risk

Thursday, July 16th, 2015

Soldiers who served in the glaring desert sunlight of Iraq and Afghanistan returned home with an increased risk of skin cancer, due not only to the desert climate, but also a lack of sun protection, Vanderbilt dermatologist Jennifer Powers, M.D., reports in a study published recently in the Journal of Investigative Dermatology. “The past decade […]

VICC’s Johnson to study cancer survivorship with immune inhibitor drugs

Thursday, March 19th, 2015

Douglas Johnson, M.D., assistant professor of Medicine, has been named a recipient of the National Comprehensive Cancer Network  (NCCN) Foundation Young Investigator Awards. The two-year grant will provide $150,000 in funding for his research on survivorship among cancer patients who receive drugs called immune checkpoint inhibitors. The formal announcement of the grant awardees was made […]

BlackHawk’s support reaches milestone

Thursday, February 12th, 2015

Country music group BlackHawk recently presented a check for $20,000 to Harold (Hal) Moses, M.D., Ingram Professor of Cancer Research and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), in support of cancer research. Since 2006, the group has raised and donated $100,000 to VICC in remembrance of one of the original members of the multi-platinum […]

Combo therapy may help fight melanoma

Thursday, January 8th, 2015

Two therapies already in clinical development as single agents may work in combination to treat many subtypes of melanoma, a recent study suggests.

Indiana Couple Supports Melanoma Research

Thursday, October 16th, 2014

Vanderbilt-Ingram Cancer Center (VICC) melanoma patient Gerald (Jerry) Schreiber and wife Phyllis organized and hosted the first annual Melanoma Research Golf Classic in Evansville, Indiana. The golf scramble raised $19,000 for VICC melanoma research spearheaded by Igor Puzanov, M.D., MSCI, associate professor of Medicine and director of Melanoma Clinical Research.

Next Page »